Anticoagulation Drugs Archives

Home › Anticoagulation Drugs

Navigating Anticoagulation Strategies and Outcomes in Patients with Cancer-Associated Thrombosis and Thrombocytopenia

Thrombocytopenia, a low platelet count (<100 × 109/L), is a common side effect of cancer and its treatment. Its...

Venous thromboembolism (VTE) is a significant concern for patients with active cancer undergoing systemic therapy, with...

Cancer patients are often prescribed more than one drug and the need to elucidate potential harmful interactions...

During the ICTHIC webinar, “Long-term treatment & DDI implications in the management of CAT,” Dr. Luis...

During the 11th ICTHIC, 2022, Jeffrey Zwicker talked about the impact of warfarin on overall survival (OS) in cancer...

Recurrent venous thromboembolism (VTE) and major bleeding are the two major challenges in managing cancer-associated...

The treatment of cancer-associated thrombosis (CAT) has changed over the last 20 years, going from warfarin up to the...

Atrial fibrillation (AF) is common in patients with cancer, and up to one in every four persons with AF has comorbid...

Patients with cancer represent a major challenge for venous thromboembolism (VTE) treatment because of their higher...

Introduction The management of cancer-associated thrombosis (CAT) is tricky because of the high risk of recurrent...